Insider Transactions in Q4 2024 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.89%
|
-
|
|
Dec 31
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+20.0%
|
-
|
|
Dec 31
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+4.94%
|
-
|
|
Dec 31
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+13.77%
|
-
|
|
Dec 31
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Dec 31
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Dec 31
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+13.56%
|
-
|
|
Dec 16
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,708
-0.9%
|
$11,956
$7.48 P/Share
|
|
Dec 16
2024
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,708
-0.49%
|
$11,956
$7.48 P/Share
|
|
Dec 16
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,063
-1.34%
|
$7,441
$7.48 P/Share
|
|
Dec 16
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
539
-1.67%
|
$3,773
$7.48 P/Share
|
|
Nov 18
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
66,667
+26.04%
|
-
|
|
Nov 07
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,700
+17.2%
|
-
|
|
Oct 02
2024
|
Mary Beth Harler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+34.66%
|
-
|